Syros Pharmaceuticals Inc (SYRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 173,984 | 93,133 | 108,674 | 116,873 | 41,731 |
| Marketable Securities | N/A | 0 | 0 | 5,003 | 49,975 |
| Receivables | 7 | 2 | 2 | N/A | 20,000 |
| Other current assets | 2,324 | 2,310 | 1,609 | 1,635 | 158 |
| TOTAL | $178,557 | $98,563 | $112,451 | $125,695 | $114,513 |
| Non-Current Assets | |||||
| PPE Net | 14,213 | 15,020 | 15,361 | 15,756 | 15,210 |
| Other Non-Current Assets | 20,480 | 19,752 | 20,004 | 19,949 | 20,255 |
| TOTAL | $34,693 | $34,772 | $35,365 | $35,705 | $35,465 |
| Total Assets | $213,250 | $133,335 | $147,816 | $161,400 | $149,978 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,603 | 4,940 | 2,803 | 4,636 | 5,853 |
| Accrued Expenses | 11,084 | 10,285 | 8,721 | 6,843 | 10,646 |
| TOTAL | $28,624 | $28,063 | $23,200 | $19,808 | $23,516 |
| Non-Current Liabilities | |||||
| Long Term Debt | 39,551 | 19,719 | 19,640 | 19,567 | N/A |
| Deferred Revenues | 12,209 | 11,177 | 10,079 | 6,795 | 5,739 |
| Other Non-Current Liabilities | 44,289 | 24,970 | 25,335 | 24,244 | 24,018 |
| TOTAL | $94,073 | $59,332 | $62,210 | $65,049 | $47,278 |
| Total Liabilities | $122,697 | $87,395 | $85,410 | $84,857 | $70,794 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 6,164 | 4,581 | 4,576 | 4,569 | 4,340 |
| Common Shares | 56 | 45 | 45 | 45 | 43 |
| Retained earnings | -377,021 | -346,891 | -327,405 | -310,209 | -292,983 |
| Other shareholders' equity | 0 | 0 | 0 | 3 | 24 |
| TOTAL | $90,553 | $45,940 | $62,406 | $76,543 | $79,184 |
| Total Liabilities And Equity | $213,250 | $133,335 | $147,816 | $161,400 | $149,978 |